about
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's candidate, cretostimogene grenaden...
Read More
41.01
3.25
(8.61%)
1.4M
XNAS Volume
XNAS 14 Nov, 2025 4:30 PM (EST)
Board Meeting
The next board meeting for Cg Oncology Inc. is on 19 Nov 2025 for the purpose of CG Oncology Inc Third Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Cg Oncology Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..